Back to trial detailsIntake questionnaire
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Applying to University of California San Francisco · San Francisco, California
Answer a few short questions to share with the research team.
0 of 4 answered